NCT04567199 is a clinical trial of Observational, retrospective in Sepsis, sponsored by Medical University Innsbruck.

Who is sponsoring NCT04567199?

NCT04567199 is sponsored by Medical University Innsbruck.

What drugs are being tested in NCT04567199?

Interventions in NCT04567199: Observational, retrospective.

What condition does NCT04567199 study?

NCT04567199 studies Sepsis, Septic Shock, Cytokine Storm, Cytokine Release Syndrome, Catecholamine.

Is NCT04567199 still recruiting?

NCT04567199 is currently completed. Last updated 3 February 2021.

Last reviewed 2021-02-03 · How we verify

NCT04567199

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Cytosorb on Amount of Catecholamine and Mortality in Sepsis

Completed Last updated 3 February 2021

What this trial tests

trial testing Observational, retrospective in Sepsis in 86 participants. Completed in 1 December 2020.

Timeline

1 December 2018

Primary endpoint
1 October 2020

1 December 2020

Quick facts

Lead sponsor	Medical University Innsbruck
Status	Completed
Study type	OBSERVATIONAL
Enrollment	86
Start date	1 December 2018
Primary completion	1 October 2020
Estimated completion	1 December 2020
Sites	1 location across Austria

Drugs / interventions tested

Observational, retrospective

Conditions studied

Sepsis — all drugs for Sepsis →
Septic Shock — all drugs for Septic Shock →
Cytokine Storm — all drugs for Cytokine Storm →
Cytokine Release Syndrome — all drugs for Cytokine Release Syndrome →

Sponsor

Medical University Innsbruck

Who can join

18 and older, any sex, with Sepsis or Septic Shock. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this retrospective study was to identify if the enrolled patient might have had a profit of Cytosorb therapy. Primarily the decline in catecholamine therapy under Cytosorb therapy will be investigated. Secondarily the outcome of surviving patients will be evaluated and compared to expected mortality due to sequential organ failure assessment (SOFA). Thirdly the patients deceased under this therapy were compared to the surviving patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective 'Genetic' Matched Analysis.
Rugg C, Klose R, Hornung R, Innerhofer N, et al · · 2020 · cited 71× · PMID 33255912 · DOI 10.3390/biomedicines8120539

Verify or expand the search:

Other recruiting trials for Sepsis

Currently open trials in the same condition.

NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting

Other Medical University Innsbruck trials

Trials by the same sponsor.

NCT07408726 — Monoaxial vs. Polyaxial Percutaneous Hybrid Stabilization · NA · not yet recruiting
NCT07101107 — Socio-cognitive and Biological Responses to Maltreatment · not yet recruiting
NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
NCT07434648 — Comparison of Mastectomy Expander Trial · NA · not yet recruiting
NCT07391683 — Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04567199 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University Innsbruck
Last refreshed: 3 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04567199.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing